Chronic fatigue syndrome: An update on treatment in primary care

Consultant

Volumn 51, Issue 3, 2011, Pages

  Khouzam, Hani Raoul ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Chronic fatigue syndrome; Management; Treatment

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; DESIPRAMINE; DONEPEZIL; DULOXETINE; ESZOPICLONE; FLUDROCORTISONE; FLUOXETINE; FLURAZEPAM; GALANTAMINE; HYDROCORTISONE; METHYLPHENIDATE; MIDODRINE; MILNACIPRAN; MIRTAZAPINE; NORTRIMIPRAMINE; PAROXETINE; PSEUDOEPHEDRINE; RAMELTEON; RIBOSE; RIVASTIGMINE; SERTRALINE; TEMAZEPAM; TRAZODONE; UNINDEXED DRUG; VENLAFAXINE; ZALEPLON; ZOLPIDEM;

ALLERGY; ATTENTION DEFICIT DISORDER; CHRONIC FATIGUE SYNDROME; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DIET THERAPY; DRUG EFFICACY; FATIGUE; HUMAN; HYGIENE; HYPOTENSION; KINESIOTHERAPY; LEISURE; MENTAL DISEASE; MENTAL PERFORMANCE; PALLIATIVE THERAPY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REST; REVIEW; SELF HELP; SLEEP DISORDER;

EID: 79954484777     PISSN: 00107069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994;121:953-959.
2. Carruthers BM, Jain AK, De Meirleir KL, et al. Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. J Chron Fatigue Syndrome. 2003;11:7-36.
3. Matsuda Y, Matsui T, Kataoka K, et al. A two-year follow-up study of chronic fatigue syndrome comorbid with psychiatric disorders. Psychiatry Clin Neurosci. 2009;63:365-373.
4. Gunn WJ, Connell DB, Randall B. Epidemiology of chronic fatigue syndrome: the Centers for Disease Control Study. Ciba Found Symp. 1993;173:83-93; discussion 93-101.
5. Cho HJ, Menezes PR, Hotopf M, et al. Comparative epidemiology of chronic fatigue syndrome in Brazilian and British primary care: prevalence and recognition. Br J Psychiatry. 2009;194:117-122.
6. Harvey SB, Wadsworth M, Wessely S, Hotopf M. Etiology of chronic fatigue syndrome: testing popular hypotheses using a national birth cohort study. Psychosom Med. 2008;70:488-495.
7. Shepherd C. The debate: myalgic encephalomyelitis and chronic fatigue syndrome. Br J Nurs. 2006;15:662-669.
8. Scheeres K, Wensing M, Severens H, et al. Determinants of health care use in chronic fatigue syndrome patients: a cross-sectional study. J Psychosom Res. 2008;65:39-46.
9. Shepherd C. Pacing and exercise in chronic fatigue syndrome. Physiotherapy. 2001;87:395-396. (Pubitemid 32734447)
10. Afari N, Buchwald D. Chronic fatigue syndrome: a review. Am J Psychiatry. 2003;160:221-236. (Pubitemid 41110447)
11. Deale A, Husain K, Chalder T, Wessely S. Long-term outcome of cognitive behavior therapy versus relaxation therapy for chronic fatigue syndrome: a 5-year follow-up study. Am J Psychiatry. 2001;158:2038-2042. (Pubitemid 33104111)
12. Prins JB, Bleijenberg G, Bazelmans E, et al. Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial. Lancet. 2001;357:841-847. (Pubitemid 32239369)
13. Roth AD, Pilling S, Turner J. Therapist training and supervision in clinical trials: implications for clinical practice. Behav Cogn Psychother. 2010;38:291-302.
14. Chambers D, Bagnall AM, Hempel S, Forbes C. Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic review. J R Soc Med. 2006;99:506-520. (Pubitemid 44690264)
15. Pae CU, Marks DM, Patkar AA, et al. Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants. Expert Opin Pharmacother. 2009;10:1561-1570.
16. Kranzler JD, Gendreau RM. Role and rationale for the use of milnacipran in the management of fibromyalgia. Neuropsychiatr Dis Treat. 2010;25:197-208.
17. Neu D, Cappeliez B, Hoffmann G, et al. High slow-wave sleep and low-light sleep: chronic fatigue syndrome is not likely to be a primary sleep disorder. J Clin Neurophysiol. 2009;26:207-212.
18. Lyall M, Peakman M, Wessely S. A systematic review and critical evaluation of the immunology of chronic fatigue syndrome. J Psychosom Res. 2003;55:79-90. (Pubitemid 37098388)
19. Wyller VB, Thaulow E, Amlie JP. Treatment of chronic fatigue and orthostatic intolerance with propranolol. J Pediatr. 2007;150:654-655. (Pubitemid 46755817)
20. Blockmans D, Persoons P, Van Houdenhove B, Bobbaers H. Does methylphenidate reduce the symptoms of chronic fatigue syndrome? Am J Med. 2006;119:167.e23-e30.
21. Kumar R. Approved and investigational uses of modafinil: an evidence-based review. Drugs. 2008;68:1803-1839.
22. Teitelbaum JE, Johnson C, St Cyr J. The use of D-ribose in chronic fatigue syndrome and fibromyalgia: a pilot study. J Altern Complement Med. 2006;12:857-862. (Pubitemid 44770977)
23. Veldman J, Van Houdenhove B, Verguts J. Chronic fatigue syndrome: a hormonal origin? A rare case of dysmenorrhea membranacea. Arch Gynecol Obstet. 2009;279:717-720.
24. Madill PV. Chronic fatigue syndrome and the cholinergic hypothesis. JAMA. 2004;292:2723; author reply 2723.
25. Lijue Z. Acupuncture and Chinese patent drugs for treatment of chronic fatigue syndrome. J Tradit Chin Med. 2005;25:99-101.
26. Vermeulen RC, Scholte HR. Exploratory open label, randomized study of acetyl- and propionylcarnitine in chronic fatigue syndrome. Psychosom Med. 2004;66:276-282. (Pubitemid 38393239)
27. Menéndez-Arias L. Evidence and controversies on the role of XMRV in prostate cancer and chronic fatigue syndrome. Rev Med Virol. 2011;21:3-17.